相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites
Xiang Zhang et al.
GUT (2021)
Combined metabolic activators therapy ameliorates liver fat in nonalcoholic fatty liver disease patients
Mujdat Zeybel et al.
MOLECULAR SYSTEMS BIOLOGY (2021)
FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption
Bethan L. Clifford et al.
CELL METABOLISM (2021)
Mitochondria regulation in ferroptosis
Hai Wang et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2020)
Evolution of NAFLD and Its Management
Manpreet S. Mundi et al.
NUTRITION IN CLINICAL PRACTICE (2020)
The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease
Nikolaos Perakakis et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
Glycine-based treatment ameliorates NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome
Oren Rom et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Progress and challenges in the prevention and control of nonalcoholic fatty liver disease
Jingjing Cai et al.
MEDICINAL RESEARCH REVIEWS (2019)
Iron and liver fibrosis: Mechanistic and clinical aspects
Kosha J. Mehta et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Indoxyl Sulfate and p-Cresyl Sulfate Promote Vascular Calcification and Associate with Glucose Intolerance
Britt Opdebeeck et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Dietary Antioxidant Supplements and Uric Acid in Chronic Kidney Disease: A Review
Stefanos Roumeliotis et al.
NUTRIENTS (2019)
Is 3-Carboxy-4-methyl-5-propyl-2-furanpropionate (CMPF) a Clinically Relevant Uremic Toxin in Haemodialysis Patients?
Mathilde Luce et al.
TOXINS (2018)
GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease
Rohit Loomba et al.
GASTROENTEROLOGY (2018)
Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis
Cristina Alonso et al.
GASTROENTEROLOGY (2017)
The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Monica D. Chow et al.
MOLECULAR ASPECTS OF MEDICINE (2017)
Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters
Enoch Cobbina et al.
DRUG METABOLISM REVIEWS (2017)
Metabolic signatures and risk of type 2 diabetes in a Chinese population: an untargeted metabolomics study using both LC-MS and GC-MS
Yonghai Lu et al.
DIABETOLOGIA (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Indoxyl Sulfate-Review of Toxicity and Therapeutic Strategies
Sheldon C. Leong et al.
TOXINS (2016)
The Role of Iron and Iron Overload in Chronic Liver Disease
Sandra Milic et al.
MEDICAL SCIENCE MONITOR (2016)
Glucagon regulates hepatic lipid metabolism via cAMP and Insig-2 signaling: implication for the pathogenesis of hypertriglyceridemia and hepatic steatosis
Hai Wang et al.
SCIENTIFIC REPORTS (2016)
The Furan Fatty Acid Metabolite CMPF Is Elevated in Diabetes and Induces β Cell Dysfunction
Kacey J. Prentice et al.
CELL METABOLISM (2014)
Oxidative stress as a crucial factor in liver diseases
Halina Cichoz-Lach et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis
Krishnendu Sinha et al.
ARCHIVES OF TOXICOLOGY (2013)
Transcription factors and coactivators controlling nutrient and hormonal regulation of hepatic gluconeogenesis
Sarawut Jitrapakdee
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
Disorders of iron metabolism. Part 1: molecular basis of iron homoeostasis
Manuel Munoz et al.
JOURNAL OF CLINICAL PATHOLOGY (2011)
On the antioxidant properties of kynurenic acid: Free radical scavenging activity and inhibition of oxidative stress
R. Lugo-Huitron et al.
NEUROTOXICOLOGY AND TERATOLOGY (2011)
Bile salt biotransformations by human intestinal bacteria
JM Ridlon et al.
JOURNAL OF LIPID RESEARCH (2006)
CREB controls hepatic lipid metabolism through nuclear hormone receptor PPAR-γ
S Herzig et al.
NATURE (2003)
Engineering central metabolism in crop species: learning the system
F Carrari et al.
METABOLIC ENGINEERING (2003)
CREB regulates hepatic gluconeogenesis through the coactivator PGC-1
S Herzig et al.
NATURE (2001)
分享论文
